Narcolepsy Market: Remarkable Exploration CAGR of 8.48% during the forecast period 2013 - 2023
Precisemarketreports.com adds new report “Narcolepsy- Market Insights, Epidemiology and Market Forecast-2023” which contains global key player’s survey information and forecast to 2022.
(EMAILWIRE.COM, November 26, 2017 ) Overview of Narcolepsy Market:
The top market research analysts estimated that the worldwide Narcolepsy will increase at a CAGR of 8.48% during the forecast period 2013-2023. PROVIGIL by Cephalon, Inc and XYREM by Jazz Pharmaceuticals is the top selling drug for Narcolepsy contributing to majority of the market share. Other drugs are also being used for the treatment of Narcolepsy as secondary indication, but do not have much impact on the overall market size.
Get a Sample Copy of this Report @
https://www.precisemarketreports.com/report/sample/pmr-62586 .
"Narcolepsy - Market Insights, Epidemiology and Market Forecast-2023" Report provides an overview of the disease and global market size of the Narcolepsy for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan. It also includes global historical and forecasted epidemiological data for the prevalent, diagnosed and treatable cases of Narcolepsy from 2013-2023.
Narcolepsy is a chronic neurological / brain disorder which involves poor control of sleep and wakefulness. Narcolepsy is classically a tetrad of symptoms including EDS, cataplexy, sleep paralysis, and hypnagogic hallucinations.
Narcolepsy affects approximately 200,000 Americans and 3 million people worldwide. Narcolepsy is not rare, but it is severely under-recognized and commonly misdiagnosed. Narcolepsy appears throughout the world but occurrence rates vary among populations. The occurrence rate of narcolepsy is remarkably lower in Israel and quite higher in Japan compared to the United States. In Europe, the occurrence rate is found to be higher in UK and Germany than other European countries.
Get a 20% Discount on Single User report spread across 99 pages @
https://www.precisemarketreports.com/report/discount/pmr-62586 .
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Key Coverage:
1. Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
2. Marketed information including available prescription drugs, its patent and exclusivity details.
3. The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2013-2023.
4. It also provides Market size of Narcolepsy for United States, EU5 and Japan from 2013 and forecasted Market size to 2023.
To know more click here ->
https://www.precisemarketreports.com/report/enquiry/pmr-62586 .
Major Points in Table of Contents:
Global Narcolepsy Market Report 2017
1 Report Introduction
2 Narcolepsy Market Overview at a Glance
3 Epidemiology of Narcolepsy in 7MM
4 Marketed (FDA / EMA Approved) Drugs
5 Global Narcolepsy: Country-Wise Market Analysis
6 Total Market Size of Narcolepsy (2013-2023)
7 Market Drivers
8 Market Barriers
9 Appendix
10 Report Methodology
11 Consulting Services
12 Disclaimer
About us:
Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.
Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us:
Precise Market Reports
Office No. 48, Akshya Complex, Dhole Patil road,
Maharashtra, Pune – 411001
India.
sales@precisemarketreports.com
+1 (323) 744 6588
https://www.precisemarketreports.com
The top market research analysts estimated that the worldwide Narcolepsy will increase at a CAGR of 8.48% during the forecast period 2013-2023. PROVIGIL by Cephalon, Inc and XYREM by Jazz Pharmaceuticals is the top selling drug for Narcolepsy contributing to majority of the market share. Other drugs are also being used for the treatment of Narcolepsy as secondary indication, but do not have much impact on the overall market size.
Get a Sample Copy of this Report @
https://www.precisemarketreports.com/report/sample/pmr-62586 .
"Narcolepsy - Market Insights, Epidemiology and Market Forecast-2023" Report provides an overview of the disease and global market size of the Narcolepsy for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan. It also includes global historical and forecasted epidemiological data for the prevalent, diagnosed and treatable cases of Narcolepsy from 2013-2023.
Narcolepsy is a chronic neurological / brain disorder which involves poor control of sleep and wakefulness. Narcolepsy is classically a tetrad of symptoms including EDS, cataplexy, sleep paralysis, and hypnagogic hallucinations.
Narcolepsy affects approximately 200,000 Americans and 3 million people worldwide. Narcolepsy is not rare, but it is severely under-recognized and commonly misdiagnosed. Narcolepsy appears throughout the world but occurrence rates vary among populations. The occurrence rate of narcolepsy is remarkably lower in Israel and quite higher in Japan compared to the United States. In Europe, the occurrence rate is found to be higher in UK and Germany than other European countries.
Get a 20% Discount on Single User report spread across 99 pages @
https://www.precisemarketreports.com/report/discount/pmr-62586 .
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Key Coverage:
1. Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
2. Marketed information including available prescription drugs, its patent and exclusivity details.
3. The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2013-2023.
4. It also provides Market size of Narcolepsy for United States, EU5 and Japan from 2013 and forecasted Market size to 2023.
To know more click here ->
https://www.precisemarketreports.com/report/enquiry/pmr-62586 .
Major Points in Table of Contents:
Global Narcolepsy Market Report 2017
1 Report Introduction
2 Narcolepsy Market Overview at a Glance
3 Epidemiology of Narcolepsy in 7MM
4 Marketed (FDA / EMA Approved) Drugs
5 Global Narcolepsy: Country-Wise Market Analysis
6 Total Market Size of Narcolepsy (2013-2023)
7 Market Drivers
8 Market Barriers
9 Appendix
10 Report Methodology
11 Consulting Services
12 Disclaimer
About us:
Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.
Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us:
Precise Market Reports
Office No. 48, Akshya Complex, Dhole Patil road,
Maharashtra, Pune – 411001
India.
sales@precisemarketreports.com
+1 (323) 744 6588
https://www.precisemarketreports.com
Contact Information:
Precise Market Reports
Parag Pingale
Tel: +1 (323) 744 6588
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Precise Market Reports
Parag Pingale
Tel: +1 (323) 744 6588
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results